CoverageForm 410-K10-Q8-K13D13G13F

BTTR · Better Choice Co Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Income Statement

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue$6.53M$34.98M$38.59M$54.66M$46.01M$42.59M
Cost of Revenue$5.01M$21.99M$26.80M$39.40M$30.64M$26.49M
Gross Profit$1.53M$12.99M$11.80M$15.26M$15.37M$16.10M
R&D-$100.0K$100.0K$500.0K$100.0K-
SG&A$12.93M$18.96M$24.44M$32.46M$34.49M$25.97M
Total Operating Expenses$12.93M$18.96M$32.98M$54.04M$32.65M$43.42M
D&A$4.39M$130.0K$1.68M$1.69M$1.66M$1.75M
Operating Income($11.41M)($5.97M)($21.18M)($38.78M)($17.28M)($27.32M)
Interest Expense$628.0K$467.0K$551.0K$551.0K-$9.20M
Income Tax$357.0K($1.24M)$267.0K($18.0K)$37.0K$0
Net Income($43.05M)($168.0K)($22.77M)($39.32M)$3.39M($59.34M)
EPS - Basic($1.95)($0.10)($32.29)($1.34)($7.26)-
EPS - Diluted($1.95)($0.10)($32.29)($1.34)($7.26)-

Balance Sheet

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash & Equivalents$1.31M$3.07M$4.46M$3.17M$21.73M$3.93M
Accounts Receivable-$5.37M$4.35M$6.74M$6.79M$4.63M
Inventory$2.08M$3.87M$6.61M$10.26M$5.25M$4.87M
Accounts Payable$2.15M$3.14M$6.93M$2.93M$4.55M$3.14M
Current Assets$8.13M$15.00M$16.23M$27.52M$43.92M$17.56M
Total Assets$8.40M$15.80M$16.74M$38.68M$74.66M$51.25M
Current Liabilities$3.54M$7.15M$13.69M$5.58M$7.34M$54.58M
Long-term Debt$1.90M$2.41M$5.29M$11.44M$9.41M$24.59M
Total Liabilities$8.00M$7.15M$13.76M$17.15M$16.79M$79.36M
Stockholders' Equity$407.0K$8.65M$2.98M$21.53M$57.88M($28.10M)
Retained Earnings($22.93M)($321.51M)($321.34M)($298.57M)($259.26M)($260.64M)

Cash Flow

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Operating Cash Flow($1.48M)($4.36M)$97.0K($20.55M)($11.86M)($7.50M)
Investing Cash Flow($1.09M)($2.25M)($18.0K)($198.0K)($353.0K)($151.0K)
Financing Cash Flow$932.0K$5.22M($5.10M)$1.28M$37.16M$9.11M
CapEx-$41.0K$18.0K$198.0K$353.0K$151.0K
Free Cash Flow-($4.40M)$79.0K($20.75M)($12.21M)($7.66M)

Ratios

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Profitability
Gross margin23.4%37.1%30.6%27.9%33.4%37.8%
Operating margin-174.6%-17.1%-54.9%-71.0%-37.6%-64.2%
EBITDA margin-107.4%-16.7%-50.5%-67.9%-33.9%-60.0%
Net margin-658.9%-0.5%-59.0%-71.9%7.4%-139.3%
Free cash flow margin--12.6%0.2%-38.0%-26.5%-18.0%
FCF / Net income-26.18-0.000.53-3.610.13
R&D / Revenue-0.3%0.3%0.9%0.2%-
SG&A / Revenue197.9%54.2%63.3%59.4%75.0%61.0%
Effective tax rate----1.1%-
Return on assets-512.4%-1.1%-136.0%-101.7%4.5%-115.8%
Return on equity-10578.4%-1.9%-764.6%-182.6%5.9%211.1%
Return on invested capital-390.1%-42.6%-202.3%-92.9%-25.4%-
Liquidity
Current ratio2.292.101.194.935.980.32
Quick ratio1.711.560.703.095.270.23
Cash ratio0.370.430.330.572.960.07
Leverage
Debt / Equity4.680.281.780.530.16-0.88
Debt / Assets0.230.150.320.300.130.48
Debt / EBITDA------
Interest coverage-18.2x-12.8x-38.4x-70.4x--3.0x
Equity multiplier20.641.835.621.801.29-1.82
Liabilities / Assets0.950.450.820.440.221.55
Efficiency
Asset turnover0.782.212.311.410.620.83
Inventory turnover2.415.684.053.845.845.44
Days sales outstanding-56d41d45d54d40d
Days inventory outstanding151d64d90d95d62d67d
Days payable outstanding156d52d94d27d54d43d
Cash conversion cycle-68d37d113d62d64d
Valuation
P / E------
P / B------
P / S------
EV / EBITDA------
Growth
Revenue growth (YoY)-81.3%-9.4%-29.4%18.8%8.0%188.1%
Revenue CAGR (3y)-50.7%-8.7%-3.2%54.6%4492.4%2806.8%
Revenue CAGR (5y)-31.3%18.8%859.3%693.8%1471.5%-
Gross profit growth (YoY)-88.3%10.1%-22.7%-0.7%-4.5%120.7%
Operating income growth (YoY)-91.2%71.8%45.4%-124.5%36.8%-429.7%
Net income growth (YoY)-25527.4%99.3%42.1%---884.6%
EPS growth (YoY)-1850.0%99.7%-2309.7%81.5%--
EPS CAGR (3y)------
EPS CAGR (5y)------
FCF growth (YoY)----69.9%-59.5%-10.4%
FCF CAGR (5y)------
Book value growth (YoY)-95.3%190.4%-86.2%-62.8%--297.4%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-09-30.

Business segments

$39.36M total
Health Solutions$39.36M · 100.0%

Geographic

$6.53M total
US$5.50M · 84.3%
TW$833.0K · 12.7%
Other$196.0K · 3.0%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

-5.34
Distress

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

3/9
Weak
  • Net income positive
  • Operating cash flow positive
  • ROA improved YoY
  • Cash flow > net income
  • Long-term debt decreased
  • Current ratio improved
  • No share dilution
  • Gross margin improved
  • Asset turnover improved

Peer comparison

Same SIC group: Beverages

CompanyRevenue (last FY)Net marginROE
STKL$817.72M1.9%9.2%
KO$47.94B27.3%40.7%
COCO--21.5%
KDP$16.60B12.5%8.1%
STZ$9.14B18.5%20.9%

Comparing Better Choice Co Inc. against the 5 most active filers in the same SIC group.

Cells marked with a small ◇ are sourced from SEC's bulk Financial Statement Data Sets, which can lose dimensional context (notably Revenue and Operating Income for issuers that report by segment). These cells will be replaced with authoritative values from the Company Facts API as the backfill completes.